Working… Menu

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) (HYDROPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02529475
Recruitment Status : Terminated (recruitment problem-covid-)
First Posted : August 20, 2015
Last Update Posted : November 18, 2020
Information provided by (Responsible Party):
University Hospital, Grenoble

Brief Summary:
  • This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects
  • MR Perfusion Imaging will be assess in both cochlea as well
  • Primary auditory brain pathways will be evaluated through MR diffusion imaging

Condition or disease Intervention/treatment Phase
Meniere Disease Drug: Gadoteric acid Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 25 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
Actual Study Start Date : February 1, 2016
Actual Primary Completion Date : September 2020
Actual Study Completion Date : September 2020

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Gadoteric acid
Gadoteric acid 0.2 mmol/kg
Drug: Gadoteric acid
Comparison with patients with Meniere's disease

Primary Outcome Measures :
  1. Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted Imaging [ Time Frame: One MR scan (4 hours) ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
  • Informed consent signed
  • Medical examination performed prior to participation in research
  • Patients without history of inner ear disease
  • Recipient of a French social security scheme

Exclusion Criteria:

  • Patients minors
  • Patients on a legal protection regime type guardianship
  • Respiratory pathologies, cardiovascular, renal, diabetes
  • Claustrophobia
  • Contraindications to exposure to a magnetic field
  • Contraindications to injecting Dotarem ®

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02529475

Layout table for location information
Grenoble, France, 38043
Hôpital Lariboisière
Paris, France, 75010
Hôpital Charles Nicolle
Rouen, France, 76038
Sponsors and Collaborators
University Hospital, Grenoble
Layout table for investigator information
Principal Investigator: Arnaud ATTYE, PH University Hospital, Grenoble
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital, Grenoble Identifier: NCT02529475    
Other Study ID Numbers: 38RC14.428
First Posted: August 20, 2015    Key Record Dates
Last Update Posted: November 18, 2020
Last Verified: November 2020
Additional relevant MeSH terms:
Layout table for MeSH terms
Meniere Disease
Endolymphatic Hydrops
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases